Suchergebnisse - (Person:"Lee, Sang Won")

PubPharm (1.466)

21

Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort

enthalten in: Seminars in arthritis and rheumatism | 2024

von Ahn, S. | Heo, S. | Ha, J. | +2

22

Biochemical characterization of a regiospecific flavonoid 3'-O-methyltransferase from orange

enthalten in: Journal of the Korean Society for Applied Biological Chemistry | 2024

von Park, H. | Bhoo, S. | Lee, S. | +1

23

Neural mechanisms of acceptance-commitment therapy for obsessive-compulsive disorder : a resting-state and task-based fMRI study

enthalten in: Psychological medicine | 2024

von Lee, S. | Kim, S. | Lee, S. | +4

24

Aberrant function of the salience network related to maltreatment experiences during thought-action fusion

enthalten in: Brain imaging and behavior | 2024

von Lee, S. | Kim, S. | Kim, Y. | +3

25

Earliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis

enthalten in: Clinical and experimental rheumatology | 2024

von Koo, G. | Ha, J. | Ahn, S. | +3

26

Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes : a single-center retrospective cohort study

enthalten in: Clinical rheumatology | 2024

von Lee, L. | Pyo, J. | Ahn, S. | +3

27

Affinity-Directed Site-Specific Protein Labeling and Its Application to Antibody-Drug Conjugates

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Kim, S. | Kim, S. | Kim, S. | +7

28

Affinity‐Directed Site‐Specific Protein Labeling and Its Application to Antibody‐Drug Conjugates

enthalten in: Advanced Science | 2024

von Kim, S. | Kim, S. | Kim, S. | +7

29

Visualization Materials Using Silicon‐Based Optical Nanodisks (ViSiON) for Enhanced NIR Imaging in Ophthalmology

enthalten in: Advanced Healthcare Materials | 2024

von Ki, J. | Lee, H. | Lee, T. | +3

30

First in human randomised trial of J2H-1702 : A novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor for non-alcoholic steatohepatitis treatment

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Kim, Y. | Lee, S. | Lee, S.

CommentIn: Aliment Pharmacol Ther. 2023 Dec;58(11-12):1238-1239. - PMID 37986603